RT Journal Article
SR Electronic
T1 Retinopathy of prematurity: screening and treatment in Costa Rica
JF British Journal of Ophthalmology
JO Br J Ophthalmol
FD BMJ Publishing Group Ltd.
SP 1709
OP 1713
DO 10.1136/bjophthalmol-2016-310005
VO 101
IS 12
A1 Tabarez-Carvajal, Ana Catalina
A1 Montes-Cantillo, Milagro
A1 Unkrich, Kelly H
A1 Trivedi, Rupal H
A1 Peterseim, Mae Millicent Winfrey
YR 2017
UL http://bjo.bmj.com/content/101/12/1709.abstract
AB Aim To determine the recent demographic data, risk factors and results of retinopathy of prematurity (ROP) screening and treatment in Costa Rica.Methods The medical records of all preterm infants meeting ROP screening criteria (≤34 weeks’ gestational age (GA) or birth weight (BW) ≤1750g, and those determined at risk by neonatologists) in the national healthcare system, Costa Rica, January 2010–December 2014, were retrospectively reviewed. The numbers and percentages of infants with ROP, risk factors, percentage of patients treated and treatment outcomes were determined. Comparison is made with screening criteria and literature reports of ROP incidence in other countries.Results The study population included 3018 preterm infants. Overall, 585 patients (585/3018, 19.4%) were found to have ROP. Of these, 15.4% (90 patients) required laser treatment, and 53% of those requiring treatment had BW <1000g. Five babies requiring treatment were ≥32 weeks’ GA but with BW ≤1750g. Aggressive posterior disease was found in nine patients, and two infants of those screened (2/3018, 0.07%) suffered severe visual impairment during the 5-year study period.Conclusion We provide comprehensive data of ROP care in Costa Rica allowing assessment and comparison of screening criteria and protocol.